AI assistant
Sending…
Cytek Biosciences, Inc. — Director's Dealing 2021
Jul 23, 2021
32966_dirs_2021-07-22_462b780a-3c41-42da-836c-362774650a83.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cytek BioSciences, Inc. (CTKB)
CIK: 0001831915
Period of Report: 2021-07-22
Reporting Person: Cameron Theresa (Director)
More from Cytek Biosciences, Inc.
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 28
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20
Regulatory Filings
2026
Jan 13
Director's Dealing
2025
Nov 21